Baseline connectome modular abnormalities in the childhood phase of a longitudinal study on individuals with chromosome 22q11.2 deletion syndrome

Autor: Zhan, L, Jenkins, LM, Zhang, A, Conte, G, Forbes, A, Harvey, D, Angkustsiri, K, Goodrich-Hunsaker, NJ, Durdle, C, Lee, A, Schumann, C, Carmichael, O, Kalish, K, Leow, AD, Simon, TJ

Publikováno v: Human brain mapping, vol 39, iss 1
Zhan, L; Jenkins, LM; Zhang, A; Conte, G; Forbes, A; Harvey, D; et al.(2018). Baseline connectome modular abnormalities in the childhood phase of a longitudinal study on individuals with chromosome 22q11.2 deletion syndrome. Human Brain Mapping, 39(1), 232-248. doi: 10.1002/hbm.23838. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/7gh3t0fp

© 2017 Wiley Periodicals, Inc. Occurring in at least 1 in 3,000 live births, chromosome 22q11.2 deletion syndrome (22q11DS) produces a complex phenotype that includes a constellation of medical complications such as congenital cardiac defects, immun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3e200bcb582e1da63b5987a70f13e95d
https://escholarship.org/uc/item/7gh3t0fp

Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

Autor: Pandey, GS, Yanover, C, Miller-Jenkins, LM, Garfield, S, Cole, SA, Curran, JE, Moses, EK, Rydz, N, Simhadri, V, Kimchi-Sarfaty, C, Lillicrap, D, Viel, KR, Przytycka, TM, Pierce, GF, Howard, TE, Sauna, ZE, Lusher, J, Chitlur, M, Ameri, A, Natarajan, K, Iyer, RV, Thompson, AA, Watts, RG, Kempton, CL, Kessler, C, Barrett, JC, Martin, EJ, Key, N, Kruse-Jarres, R, Lessinger, C, Pratt, KP, Josephson, N, McRedmond, K, Withycombe, J, Walsh, C, Matthews, D, Mahlangu, J, Krause, A, Schwyzer, R, Thejpal, R, Rapiti, N, Goga, Y, Coetzee, M, Stones, D, Mann, K, Butenas, S, Almasy, L, Blangero, J, Carless, M, Raja, R, Reed, E

Publikováno v: Pandey, GS; Yanover, C; Miller-Jenkins, LM; Garfield, S; Cole, SA; Curran, JE; et al.(2013). Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A. Nature Medicine, 19(10), 1318-1324. doi: 10.1038/nm.3270. UCSF: Retrieved from: http://www.escholarship.org/uc/item/17x2x1k8

Neutralizing antibodies (inhibitors) to replacement factor VIII (FVIII, either plasma derived or recombinant) impair the effective management of hemophilia A. Individuals with hemophilia A due to major deletions of the FVIII gene (F8) lack antigenica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::4b8311dd7fc1de6def818caf0d91b00f
http://www.escholarship.org/uc/item/17x2x1k8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.